Lund, Sweden

Carita Nordén

This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carita Nordén. Retrieved from https://idiyas.com/inventor/carita-nordén

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Carita Nordén: Innovator in Pharmaceutical Science

Introduction

Carita Nordén is a prominent inventor based in Lund, Sweden. She has made significant contributions to the field of pharmaceutical science, particularly in the development of novel compounds for treating various allergic conditions.

Latest Patents

Carita holds a patent for "Tetrahydroquinoline derivatives as STAT6-modulators, preparation and use thereof." This patent describes compounds of formula (I) that act as modulators of the STAT6 signal pathway activity. These compounds can be utilized in the treatment of atopic dermatitis, urticaria, allergic asthma, allergic rhinitis, food allergies, allergic conjunctivitis, hay fever, bullous pemphigoid, industrial sensitization, chronic rejection of transplants, or COPD. She has 1 patent to her name.

Career Highlights

Carita is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. Her work focuses on innovative solutions to address unmet medical needs in the field of allergy and immunology.

Collaborations

Throughout her career, Carita has collaborated with notable colleagues, including Håkan Bladh and Thomas Hansson. These partnerships have contributed to her success in advancing research and development in her field.

Conclusion

Carita Nordén's work exemplifies the impact of innovative research in the pharmaceutical industry. Her contributions continue to pave the way for new treatments that improve the quality of life for individuals suffering from allergic conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…